Brief: Vyne Reports Positive Preclinical Data For Intra-Articular Injection Of Pan-Bet Inhibitor, Vyn201, In An In Vivo Model Of Rheumatoid Arthritis

YARROW BIOSCIENCE

30/03/2022 13:53

March 30 (Reuters) - Vyne Therapeutics Inc  VYNE.O :
    * VYNE REPORTS POSITIVE PRECLINICAL DATA FOR INTRA-ARTICULAR
INJECTION OF PAN-BET INHIBITOR, VYN201, IN AN IN VIVO MODEL OF
RHEUMATOID ARTHRITIS
    * VYNE THERAPEUTICS - VYN201 DEMONSTRATED STATISTICALLY
SIGNIFICANT IMPROVEMENT IN TREATMENT RESPONSE FOR BOTH ENDPOINTS
AT 1MG/KG AND 10MG/KG DOSES
    * VYNE-VYN201 DEMONSTRATED NUMERICALLY SUPERIOR RESULTS AT
1MG/KG
AND 10MG/KG DOSES COMPARED TO DEXAMETHASONE IN INHIBITING
INFLAMMATION
    * SAYS DATA SUPPORTS POTENTIAL BROAD UTILITY OF VYN201 AS A
POTENT

Source text for Eikon:  ID:nGNXbc3ZMx 
Further company coverage:  VYNE.O